Alzheimer's Disease International (2009). World Alzheimer Report 2009.
Alzheimer's Disease International (2015). World Alzheimer Report 2015.
American Geriatrics Society Beers Criteria Update Expert Panel (2015). American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. Journal of The American Geriatrics Society, 63, 2227–2246.
Azermai, M., Petrovic, M., Elseviers, M. M., Bourgeois, J., Van Bortel, L. M. and Vander Stichele, R. H. (2012). Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Research Reviews, 11, 78–86.
Ballard, C. G., O'Brien, J. T., Reichelt, K. and Perry, E. K. (2002). Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind placebo-controlled trial with Melissa. Journal of Clinical Psychiatry, 63, 553– 558.
Burns, A. et al. (2011). A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 31, 158–164.
Cerejeira, J., Lagarto, L. and Mukaetova-Ladinska, E. B. (2012). Behavioral and psychological symptoms of dementia. Frontiers of Neurology, 3, 73.
Chen, Y., Briesacher, B. A., Field, T. S., Tjia, J., Lau, D. T. and Gurwitz, J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 89–95.
Cochrane Collaboration (2014). RevMan. Informatics and knowledge management Department.
Corbett, A. and Ballard, C. (2012). Antipsychotics and mortality in dementia. American Journal of Psychiatry, 169, 7–9.
Douglas, I. J. and Smeeth, L. (2008). Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ, 337, a1227.
Forbes, D., Forbes, S. C., Blake, C. M, Thiessen, E. J. and Forbes, S. (2015). Exercise programs for people with dementia. Cochrane Database of Systematic Reviews, 4, CD006489.
Forrester, L. T., Maayan, N., Orrell, M., Spector, A. E., Buchan, L. D. and Soares-Weiser, K. (2014). Aromatherapy for dementia. Cochrane Database of Systematic Reviews, 2, CD003150.
Guyatt, G. et al. (2011). GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, 64, 383–394.
Higgins, J. and Green, S. (2011). Cochrane Handbook for Systematic Reviews of Interventions. London, UK: The Cochrane Collaboration.
Hurt, C. et al. (2008). Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia. Dementia and Geriatric Cognitive Disorders, 26, 138–146.
Jansen, S., Forbes, D., Duncan, V., Morgan Debra, G. and Malouf, R. (2011). Melatonin for the treatment of dementia. Cochrane Database of Systematic Reviews, 1, CD003802.
Laver, K., Dyer, S., Whitehead, C., Clemson, L. and Crotty, M. (2016). Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews. BMJ Open, 6, e010767.
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C. and Breitner, J. C. (2000). Mental and behavioral disturbances in dementia: findings from the cache county study on memory in aging. American Journal of Psychiatry, 157, 708–714.
Ma, H. et al. (2014). The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. Journal of Alzheimer's Disease, 42, 915–937.
Moher, D., Altman, D. G., Liberati, A. and Tetzlaff, J. (2011). PRISMA statement. Epidemiology, 22, 128.
Moniz Cook, E. D., Swift, K., James, I., Malouf, R., De Vugt, M. and Verhey, F. (2012). Functional analysis-based interventions for challenging behaviour in dementia. Cochrane Database of Systematic Reviews, 2, CD006929.
Moore, M., Zhu, C. and Clipp, E. (2001). Informal costs of dementia care: estimates from the national longitudinal caregiver study. Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 56, S219–S228.
National Institute for Health and Clinical Excellence-Social Care Institute for Excellence (2007). Dementia. A NICE–SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care. London, UK: National Clinical Practice Guideline London.
Nelson, J. and Devanand, D. P. (2011). A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. Journal of the American Geriatrics Society, 59, 577–585.
Orgeta, V., Qazi, A., Spector, A. E. and Orrell, M. (2014). Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews, 1, CD009125.
Pieper, M. J. C. et al. (2013). Interventions targeting pain or behaviour in dementia: a systematic review. Ageing Research Reviews, 12, 1042–1055.
Savva, G. M. et al. (2009). Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry, 194, 212–219.
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943.
Seitz, D. P., Adunuri, N., Gill Sudeep, S., Gruneir, A., Herrmann, N. and Rochon, P. (2011). Antidepressants for agitation and psychosis in dementia. Cochrane Database of Systematic Reviews, 2, CD008191.
Seitz, D. P. et al. (2013). Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. International Psychogeriatrics, 25, 185–203.
Shea, B. J. et al. (2007). Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology, 7, 10.
Steele, C., Rovner, B., Chase, G. A. and Folstein, M. (1990). Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. American Journal of Psychiatry, 147, 1049–1051.
Tan, C. C. et al. (2014). Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis (Provisional abstract). Journal of Alzheimer's Disease, 41, 615–631.
Ueda, T., Suzukamo, Y., Sato, M. and Izumi, S. (2013). Effects of music therapy on behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Ageing Research Reviews, 12, 628–641.
Van't Leven, N., Prick, A. E., Groenewoud, J. G., Roelofs, P. D., Lange, J. and Pot, A. M. (2013). Dyadic interventions for community-dwelling people with dementia and their family caregivers: a systematic review (Provisional abstract). International Psychogeriatrics, 25, 1581–1603.
Woods, B., Aguirre, E., Spector, A. E. and Orrell, M. (2012). Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database of Systematic Reviews, 2, CD005562.
Woods, B., Spector, A., Jones, C., Orrell, M. and Davies, S. (2005). Reminiscence therapy for dementia. Cochrane Database of Systematic Reviews, 2, CD001120.